Fig. 5
From: NORAD-sponged miR-378c alleviates malignant behaviors of stomach adenocarcinoma via targeting NRP1
miR-378c inhibitor promotes malignant behaviors of STAD cells via NRP1. qRT-PCR (A) and Western blotting (B) were performed to determine NRP1 and NRP2 expressions in NRP1-silenced MGC-803 and MKN-28 cells. BrdU staining (C, scale bar, 100Ā Ī¼m) and Transwell (D, scale bar, 100Ā Ī¼m) assay were respectively applied to evaluate cell proliferation and invasion. The EMT-related proteins were determined by Western blotting (E). **Pā<ā0.01, ***Pā<ā0.001. Data represent at least three independent sets of experiment